Bioavailability of Apocynin Through Its Conversion to Glycoconjugate but Not to Diapocynin

Qun Wang; Robert E. Smith; Ron Luchtefeld; Albert Y. Sun; Agnes Simonyi; Rensheng Luo; Grace Y. Sun

doi:10.1016/j.phymed.2007.09.019

Bioavailability of Apocynin Through Its Conversion to Glycoconjugate but Not to Diapocynin

Qun Wang
, Robert E. Smith
, Ron Luchtefeld
, Albert Y. Sun
, Agnes Simonyi
, Rensheng Luo
, Grace Y. Sun

University of Missouri-St. Louis

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Phytomedicine
Volume	15
DOIs	https://doi.org/10.1016/j.phymed.2007.09.019
State	Published - Jun 1 2008

Disciplines

Biochemistry

Access to Document

10.1016/j.phymed.2007.09.019License: Unspecified

Cite this

@article{6719923680654a3a8ee11be2718f8c28,

title = "Bioavailability of Apocynin Through Its Conversion to Glycoconjugate but Not to Diapocynin",

author = "Qun Wang and Smith, \{Robert E.\} and Ron Luchtefeld and Sun, \{Albert Y.\} and Agnes Simonyi and Rensheng Luo and Sun, \{Grace Y.\}",

note = "Apocynin (4-hydroxy-3-methoxyacetophenone) is a major active ingredient from the rhizomes of Picrorhiza kurroa, a botanical plant used as an herbal medicine for treatment of a number of inflammatory diseases. Recently, apocynin is regarded as a specific inhibitor for NADPH oxidase in cell and animal models.",

year = "2008",

month = jun,

day = "1",

doi = "10.1016/j.phymed.2007.09.019",

language = "American English",

volume = "15",

journal = "Phytomedicine",

}

TY - JOUR

T1 - Bioavailability of Apocynin Through Its Conversion to Glycoconjugate but Not to Diapocynin

AU - Wang, Qun

AU - Smith, Robert E.

AU - Luchtefeld, Ron

AU - Sun, Albert Y.

AU - Simonyi, Agnes

AU - Luo, Rensheng

AU - Sun, Grace Y.

N1 - Apocynin (4-hydroxy-3-methoxyacetophenone) is a major active ingredient from the rhizomes of Picrorhiza kurroa, a botanical plant used as an herbal medicine for treatment of a number of inflammatory diseases. Recently, apocynin is regarded as a specific inhibitor for NADPH oxidase in cell and animal models.

PY - 2008/6/1

Y1 - 2008/6/1

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527211/

U2 - 10.1016/j.phymed.2007.09.019

DO - 10.1016/j.phymed.2007.09.019

M3 - Article

VL - 15

JO - Phytomedicine

JF - Phytomedicine

ER -

Bioavailability of Apocynin Through Its Conversion to Glycoconjugate but Not to Diapocynin

Disciplines

Access to Document

Other files and links

Cite this